ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIRO..CY..TRBGCZEEHUPLSK..HRIS..............................*JDIM360 Ver 2.15 (14 Jul 2008) - 2999001/01971338CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120110921W184deBibliographieenBibliographyfrBibliographieEP06820566.5200612192008070320090129enenen052612120051222GB061070620060531GB2011092120113820080924200839201103092011102010083120110921201138A61K 31/517 20060101AFI20070820BHEP A61K 31/519 20060101ALI20070820BHEP A61P 35/00 20060101ALI20070820BHEP deKOMBINATION VON ZD6474 UND PEMETREXEDenCOMBINATION OF ZD6474 AND PEMETREXEDfrCOMBINAISON DE ZD6474 ET DE PEMETREXEDHUBER PETER E ET AL: "Trimodal cancer treatment: Beneficial effects of combined antianglogenesis, radiation, and chemotherapy" CANCER RESEARCH, vol. 65, no. 9, May 2005 (2005-05), pages 3643-3655,3633, XP002464232 ISSN: 0008-5472BISCHOF M ET AL: "Triple combination of irradiation, chemotherapy (pemetrexed), and VEGFR inhibition (SU5416) in human endothelial and tumor cells" INTERNATIONAL JOURNAL OF RADIATION: ONCOLOGY BIOLOGY PHYSICS, PERGAMON PRESS, US, vol. 60, no. 4, 15 November 2004 (2004-11-15), pages 1220-1232, XP004618608 ISSN: 0360-3016GLADE-BENDER J ET AL: "VEGF BLOCKING THERAPY IN THE TREATMENT OF CANCER" EXPERT OPINION ON BIOLOGICAL THERAPY, ASHLEY, LONDON, GB, vol. 3, no. 2, April 2003 (2003-04), pages 263-276, XP009060849 ISSN: 1471-2598SRIDHAR SRIKALA S ET AL: "Targeting angiogenesis: a review of angiogenesis inhibitors in the treatment of lung cancer." LUNG CANCER (AMSTERDAM, NETHERLANDS) DEC 2003, vol. 42 Suppl 1, December 2003 (2003-12), pages S81-S91, XP002464233 ISSN: 0169-5002WEDGE, Stephen, RobertAstraZeneca R & D Alderley Alderley Park MacclesfieldCheshire SK10 4TGGBRYAN, Anderson, JosephAstraZeneca R & D Alderley Alderley Park Macclesfield Cheshire SK10 4TGGBAstraZeneca AB100080204102056-1X EP151 85 SödertäljeSEATBEBGCHCYCZDEDKEEESFIFRGBGRHUIEISITLILTLULVMCNLPLPTROSESISKTRHR20080929GB200600475020061219enWO200707195820070628200726